These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 17228784)

  • 1. [Present status in and future prospects for development of protein function inhibitors for gynecologic neoplasms].
    Wake N
    Fukuoka Igaku Zasshi; 2006 Nov; 97(11):311-4. PubMed ID: 17228784
    [No Abstract]   [Full Text] [Related]  

  • 2. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shortcut to death.
    Leslie M
    Sci Aging Knowledge Environ; 2006 May; 2006(9):nf15. PubMed ID: 16723636
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression.
    Quereda V; Martinalbo J; Dubus P; Carnero A; Malumbres M
    Oncogene; 2007 Dec; 26(55):7665-74. PubMed ID: 17599058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting p53 for enhanced radio- and chemo-sensitivity.
    Lu C; El-Deiry WS
    Apoptosis; 2009 Apr; 14(4):597-606. PubMed ID: 19259822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC; Zhang T; Lee LH; Shen S
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular targeting therapy for gynecologic cancer].
    Hatae M; Nakamura T; Onishi Y; Yamamoto F
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):233-237. PubMed ID: 18372513
    [No Abstract]   [Full Text] [Related]  

  • 8. P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.
    Cui Q; Yu JH; Wu JN; Tashiro S; Onodera S; Minami M; Ikejima T
    Acta Pharmacol Sin; 2007 Jul; 28(7):1057-66. PubMed ID: 17588343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
    Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
    Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of caveolin-1 affects bleomycin-induced growth arrest and cellular senescence in A549 cells.
    Linge A; Weinhold K; Bläsche R; Kasper M; Barth K
    Int J Biochem Cell Biol; 2007; 39(10):1964-74. PubMed ID: 17662641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle regulation in the inner ear sensory epithelia: role of cyclin D1 and cyclin-dependent kinase inhibitors.
    Laine H; Sulg M; Kirjavainen A; Pirvola U
    Dev Biol; 2010 Jan; 337(1):134-46. PubMed ID: 19854167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions.
    Cánepa ET; Scassa ME; Ceruti JM; Marazita MC; Carcagno AL; Sirkin PF; Ogara MF
    IUBMB Life; 2007 Jul; 59(7):419-26. PubMed ID: 17654117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genital lichen sclerosus et atrophicans: a precancerous condition?].
    Korge B
    Hautarzt; 2008 Jan; 59(1):77. PubMed ID: 18217174
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the correlation between genetic and immunohistochemical markers (RB1, p16 and p53 gene regultors of a cell cycle) in sporadic mammary gland carcinoma].
    Nemtsova MV; Zemliakova VV; Kuznetsova EV; Babenko OV; Zavalishina LE; Andreeva IuIu; Bateva MV; Frank GA; Zaletaev DV
    Arkh Patol; 2007; 69(2):3-6. PubMed ID: 17642181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonality in gynecologic neoplasms: is it time to reevaluate clonality studies in gynecologic neoplasms? Is it possible to confirm multicentricity with clonality studies?
    Silva EG; Matias-Guiu X
    Ann Diagn Pathol; 2012 Aug; 16(4):312-4. PubMed ID: 22417864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonogenic assays for gynecologic malignancies. Methodology and results. EORTC Preclinical Therapeutic Models Groups (PTMG).
    Aapro MS
    Contrib Gynecol Obstet; 1994; 19():24-9. PubMed ID: 7995050
    [No Abstract]   [Full Text] [Related]  

  • 18. Bibliography. Current world literature. Gynecologic cancer.
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):82-93. PubMed ID: 17218857
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hereditary gynecologic cancer: the pathologist's point of view].
    Sabourin JC
    Ann Pathol; 2010 Nov; 30(5 Suppl 1):88-9. PubMed ID: 21055556
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research on molecular genetics in gynecologic tumor: development and regulation].
    Wang Y
    Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):643-5. PubMed ID: 9387520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.